On Wednesday, in the course of current trade, Shares of Kohl’s Corp. (NYSE:KSS), lost -0.36%, and is now trading at $66.26.
The Wisconsin State Fair, the Wisconsin State Fair Park Foundation and Kohl’s Corporation, declared they will celebrate the fifth year of their partnership, offering local families access to the Fair at a fantastic value. The renewed partnership comprises the annual Kohl’s Family Value Day on Monday, August 10 from 8 a.m. until 6 p.m., where youth 11 and under will receive FREE admission (a $6 savings from the ticket price) and adults will receive admission for only $5 (a $7 savings from the ticket price). In addition, the partnership comprises the return of the popular Kohl’s Activity Zone and “Fair Day” at Children’s Hospital of Wisconsin.
“Kohl’s knows Wisconsin families look forward to attending the Fair on Kohl’s Family Value Day, and we are proud to provide fairgoers the opportunity to attend the Fair at a value they can feel good about,” said Bevin Bailis, Kohl’s senior vice president of communications and public relations. “We are also excited to again offer the Kohl’s Activity Zone, an area focused on inspiring young imaginations through educational and hands-on programs from some of the most premier organizations in Milwaukee.”
Kohl’s Corporation operates department stores in the United States. It offers private label, exclusive, and national brand apparel, footwear, accessories, beauty, and home products to children, men, and women customers.
During an Afternoon trade, Shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), dipped -3.94%, and is now trading at $4.14.
Eisai Inc. and Arena Pharmaceuticals, declared that lorcaserin HCl data will be presented at the following medical meetings:
American Thoracic Society International Conference taking place in Denver, Colorado, May 15-20, 2015, Lorcaserin for Smoking Cessation Treatment in Cigarette Smokers: A Randomized Phase 2 Trial, Poster Number: 118.
This study evaluated the efficacy of lorcaserin 10 mg twice daily for smoking cessation and body weight change in a population of dependent smokers over placebo.
Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight administration in adults. It is also developing a portfolio of programs in various therapeutic areas, counting cardiovascular, central nervous system, and metabolic diseases.
Finally, Scorpio Tankers Inc. (NYSE:STNG), gained 1.08% Wednesday.
Scorpio Tankers, declared that it has reached agreements to purchase four LR2 product tankers and has recently taken delivery of three newbuilding vessels.
LR2 Newbuildings
The Company reached agreements with two unrelated third parties to purchase an aggregate of four LR2 product tankers presently under construction at Sungdong Shipbuilding and Marine Engineering Co., Ltd. and Daehan Shipbuilding Co., Ltd. for about $60.0 million each. These vessels are predictable to be delivered between June and August 2015.
Newbuilding Vessel Deliveries
The Company recently took delivery of the following vessels:
- STI Lauren, an LR2 product tanker, was delivered from Daewoo Shipbuilding and Marine Engineering of South Korea in April 2015. Upon delivery, this vessel began a voyage for 57 days at about $37,000 per day
- STI Connaught, an LR2 product tanker, was delivered from Hyundai Samho Heavy Industries of South Korea in May 2015. Upon delivery, this vessel began a voyage for 60 days at about $34,000 per day.
- STI Osceola, an MR product tanker, was delivered from Hyundai Mipo Dockyard of South Korea in April 2015. Upon delivery, this vessel began a time charter for up to 120 days at about $19,500 per day.
Scorpio Tankers Inc., together with its auxiliaries, engages in the seaborne transportation of refined petroleum products and crude oil worldwide. As of March 31, 2015, it owned 67 tankers comprising 11 LR2 tanker, 2 LR1 tankers, 15 Handymax tankers, 39 MR tankers with an average age of 1.1 years; and time charters-in 20 product tankers, counting 5 LR2, 5 LR1, 3 MR, and 7 Handymax tankers.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
